Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
NeuBase Therapeutics, Inc. (NBSE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
14 Sep 2023
Symetryx Corp
10% Owner
NeuBase Therapeutics, Inc.
(NBSE)
0
-100%
282,445
$1.33
$375,620.16
SELL
7 Sep 2023
Symetryx Corp
10% Owner
NeuBase Therapeutics, Inc.
(NBSE)
472,926
-30%
207,075
$1.63
$336,730.94
BUY
1 Sep 2023
Symetryx Corp
10% Owner
NeuBase Therapeutics, Inc.
(NBSE)
680,081
+9%
61,076
$0.98
$59,732.33
BUY
30 Mar 2022
Mann William Roland
Chief Operating Officer, Officer
NeuBase Therapeutics, Inc.
(NBSE)
11,200
+124%
6,200
$1.92
$11,904.00
BUY
18 Mar 2022
Branning Todd P.
Chief Financial Officer, Officer
NeuBase Therapeutics, Inc.
(NBSE)
30,000
+50%
10,000
$1.81
$18,100.00
BUY
16 Mar 2022
Branning Todd P.
Chief Financial Officer, Officer
NeuBase Therapeutics, Inc.
(NBSE)
20,000
+100%
20,000
$1.68
$33,600.00
BUY
1 Mar 2022
RICHMAN ERIC I
Director
NeuBase Therapeutics, Inc.
(NBSE)
44,960
+9%
3,880
$1.64
$6,352.40
BUY
18 Jun 2021
GOLDSTEIN DOV A MD
Director
NeuBase Therapeutics, Inc.
(NBSE)
30,000
+36%
8,000
$4.75
$38,000.00
BUY
26 Apr 2021
Stephan Dietrich A
President and CEO, Director, Officer, 10% Owner
NeuBase Therapeutics, Inc.
(NBSE)
24,525
+95%
12,000
$5.00
$60,000.00
BUY
26 Apr 2021
GOLDSTEIN DOV A MD
Director
NeuBase Therapeutics, Inc.
(NBSE)
22,000
+120%
12,000
$5.00
$60,000.00
BUY
26 Apr 2021
RICHMAN ERIC I
Director
NeuBase Therapeutics, Inc.
(NBSE)
41,080
+13%
5,000
$5.00
$25,000.00
BUY
26 Apr 2021
Mann William Roland
COO, Officer
NeuBase Therapeutics, Inc.
(NBSE)
5,000
+100%
5,000
$5.00
$25,000.00
BUY
9 Jun 2020
Stephan Dietrich A
President and CEO, Director, Officer, 10% Owner
NeuBase Therapeutics, Inc.
(NBSE)
12,525
+11%
1,275
$7.73
$9,860.72
BUY
21 May 2020
Stephan Dietrich A
President and CEO, Director, Officer, 10% Owner
NeuBase Therapeutics, Inc.
(NBSE)
11,250
+12%
1,250
$8.09
$10,111.00
BUY
30 Apr 2020
Stephan Dietrich A
President and CEO, Director, Officer, 10% Owner
NeuBase Therapeutics, Inc.
(NBSE)
10,000
+100%
10,000
$6.00
$60,000.00
BUY
30 Apr 2020
GOLDSTEIN DOV A MD
Director
NeuBase Therapeutics, Inc.
(NBSE)
10,000
+100%
10,000
$6.00
$60,000.00
BUY
30 Apr 2020
RICHMAN ERIC I
Director
NeuBase Therapeutics, Inc.
(NBSE)
27,747
+64%
10,833
$6.00
$64,998.00
BUY
30 Apr 2020
Backenroth Samuel
CFO, Treasurer & Secretary, Officer
NeuBase Therapeutics, Inc.
(NBSE)
11,630
+9%
1,000
$6.00
$6,000.00
BUY
10 Apr 2017
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
1,067,898
+0%
7,142.9
$14.00
$100,000.60
BUY
10 Apr 2017
HIRSCHMAN ORIN
Director
Ohr Pharmaceutical Inc
(OHRP)
1,649,605
+0%
7,142.9
$14.00
$100,000.60
BUY
10 Apr 2017
Backenroth Samuel
Chief Financial Officer, Officer
Ohr Pharmaceutical Inc
(OHRP)
212,596
+1%
3,571.45
$14.00
$50,000.30
BUY
20 Jun 2016
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
917,954
+0%
439.3
$56.91
$24,999.70
BUY
20 Jun 2016
Backenroth Samuel
Chief Financial Officer, Officer
Ohr Pharmaceutical Inc
(OHRP)
138,709
+0%
123.4
$56.71
$6,997.44
BUY
25 May 2016
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
913,072
+0%
184.1
$62.18
$11,446.65
BUY
23 May 2016
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
905,269
+0%
1,403.4
$62.97
$88,377.06
BUY
23 May 2016
Backenroth Samuel
Chief Financial Officer, Officer
Ohr Pharmaceutical Inc
(OHRP)
136,362
+0%
125
$63.41
$7,926.01
BUY
11 Apr 2016
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
884,504
+0%
312.5
$67.00
$20,937.50
BUY
7 Mar 2016
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
873,527
+0%
312.5
$72.54
$22,668.92
BUY
22 Feb 2016
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
865,854
+0%
312.5
$62.18
$19,431.50
BUY
19 Jan 2016
Slakter Jason Scott
Chief Executive Officer, Director, Officer
Ohr Pharmaceutical Inc
(OHRP)
859,604
+0%
312.5
$72.34
$22,605.70
Home